Researching MECFS Priority Area

Application Platform: Applications must be submitted through the relevant UKRI funding opportunity used for the project.

Application Sections: Determined by the specific MRC funding scheme used.

Assessment Process: Applications are assessed through the standard MRC peer review and panel decision process associated with the selected funding scheme.

Co-Funders: Not specified

Collaboration Rules: Collaborative and multidisciplinary research teams are encouraged, including partnerships with researchers new to the ME/CFS field.

Competitiveness: Not specified

Consortium Requirements: Not mandatory but multidisciplinary teams are encouraged to address complex research challenges.

Decision Risks: Applications may be rejected if they fall outside MRC remit, fail to meet eligibility criteria, or do not demonstrate strong scientific quality and relevance to ME/CFS research priorities.

Decision Timeline: Determined by the standard timelines of the selected MRC funding scheme.

Eligible Expenses: Research staff salaries, research costs, equipment, travel, and other eligible project costs according to the selected MRC funding scheme.

Eligible Scope: Research addressing priority areas such as causes of post-exertional malaise, diagnostic tool development, immune system involvement, genetic links, disease severity drivers, mitochondrial dysfunction, oxygenation dysfunction, and drug repurposing.

Funding Intensity: MRC typically funds up to 80% of the Full Economic Cost of the project.

Important Notes: Applications under this priority area may receive prioritisation for funding compared with other proposals achieving the same assessment score. Applicants are encouraged to include patient and public involvement in the research design.

Ineligible Projects: Projects that fall outside MRC’s remit or do not meet the requirements of the specific funding scheme used.

International Collaboration Requirement: International project co-leads may be included if they provide expertise not available in the UK.

Interview Stage: Determined by the specific MRC funding scheme used.

Key Requirements: Applications should address key research priorities identified by the ME/CFS Priority Setting Partnership and aim to advance understanding, diagnosis, or treatment of ME/CFS.

Lead Organisation Requirement: The lead organisation must meet the eligibility requirements for the specific MRC funding scheme used.

Match Funding Requirement: Not specified beyond the standard funding rules of the selected MRC funding scheme.

Project Duration: Determined by the specific MRC funding opportunity used

Project End Date: Determined by the selected MRC funding scheme

Project Start Date: Determined by the selected MRC funding scheme

Publication Date: 2003-05-01 00:00:00

Renewal Rules: Not specified

Research Category: Medical and biomedical research focused on ME/CFS.

Research Organisation Funding: Host organisations must provide appropriate research infrastructure and support for the project.

Subcontractors: Not specified

Total Fund Available: Not specified